Axovant Gene Therapies
Axovant Gene Therapies is a biotechnology company focused on developing innovative gene therapies for patients with serious neurological and neuromuscular disorders. Leveraging advanced genetic engineering and delivery technologies, Axovant aims to address unmet medical needs by targeting the underlying causes of rare and debilitating diseases. The company’s pipeline includes investigational gene therapy candidates designed to provide durable clinical benefits and improve patient outcomes. Committed to scientific excellence and rigorous clinical research, Axovant Gene Therapies collaborates with leading partners in the biotech and healthcare sectors to accelerate the development and commercialization of transformative gene therapy solutions.
